BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 25252438)

  • 1. [The diagnostic impact and limitations of 24 hour pH monitoring with multichannel intraluminal impedance].
    Korszun K; Dyrla P; Wojtuń S; Gil J
    Pol Merkur Lekarski; 2014 Aug; 37(218):73-6. PubMed ID: 25252438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel.
    Jobe BA; Richter JE; Hoppo T; Peters JH; Bell R; Dengler WC; DeVault K; Fass R; Gyawali CP; Kahrilas PJ; Lacy BE; Pandolfino JE; Patti MG; Swanstrom LL; Kurian AA; Vela MF; Vaezi M; DeMeester TR
    J Am Coll Surg; 2013 Oct; 217(4):586-97. PubMed ID: 23973101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus.
    Waśko-Czopnik D; Błoński W; Paradowski L
    Adv Med Sci; 2007; 52():196-8. PubMed ID: 18217418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current applications of evolving methodologies in gastroesophageal reflux disease testing.
    Weber C; Davis CS; Fisichella PM
    Dig Liver Dis; 2011 May; 43(5):353-7. PubMed ID: 21324762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of gastroesophageal reflux disease.
    Dughera L; Navino M; Cassolino P; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
    Malhotra A; Freston JW; Aziz K
    J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
    Hong SK; Vaezi MF
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing.
    Kline MM; Ewing M; Simpson N; Laine L
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):880-5; quiz 836. PubMed ID: 18424190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
    Blonski W; Vela MF; Castell DO
    J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal impedance-pH monitoring.
    Sifrim D; Fornari F
    Dig Liver Dis; 2008 Mar; 40(3):161-6. PubMed ID: 18082474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined esophageal multichannel intraluminal impedance and pH monitoring after repair of esophageal atresia.
    Fröhlich T; Otto S; Weber P; Pilic D; Schmidt-Choudhury A; Wenzl TG; Köhler H
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):443-9. PubMed ID: 18852636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is impedance pH monitoring superior to the conventional 24-h pH meter in the evaluation of patients with laryngorespiratory symptoms suspected to be due to gastroesophageal reflux disease?
    Ang D; Ang TL; Teo EK; Hsu PP; Tee A; Poh CH; Tan J; Ong J; Fock KM
    J Dig Dis; 2011 Oct; 12(5):341-8. PubMed ID: 21955426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.